The International Society of Pharmacovigilance Vaccines Special Interest Group: Challenges and Opportunities.
作者信息
Chandler Rebecca E
机构信息
International Society of Pharmacovigilance, London, UK.
出版信息
Drug Saf. 2022 Jun;45(6):597-599. doi: 10.1007/s40264-022-01179-y. Epub 2022 May 9.
PMID:35532845
Abstract
摘要
相似文献
[1]
[2]
[4]
[5]
[6]
Vaccine pharmacovigilance in India: Current context and future perspective.
Indian J Pharmacol. 2019
[7]
[8]
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and Prevention.
Expert Rev Vaccines. 2019-10-19
[9]
Which pharmacovigilance for vaccines?
Bull Acad Natl Med. 2016-2
引用本文的文献
本文引用的文献
[1]
Menstrual Symptoms After COVID-19 Vaccine: A Cross-Sectional Investigation in the MENA Region.
Int J Womens Health. 2022-3-28
[2]
Evaluation of menstrual irregularities after COVID-19 vaccination: Results of the MECOVAC survey.
Open Med (Wars). 2022-3-9
[3]
[4]
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel.
N Engl J Med. 2021-12-2
[5]
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
N Engl J Med. 2021-6-3
[6]
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.
N Engl J Med. 2021-6-3
[7]
[8]
[9]
Adversomics: a new paradigm for vaccine safety and design.
Expert Rev Vaccines. 2015-7
Zotero 插件